Piscataway, NJ, January 30, 2023–Camber Pharmaceuticals is pleased to announce the addition of Memantine HCl Tablets to its current portfolio.
Memantine HCl Tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Memantine HCl Tablets are available in 5 and 10 mg strengths and supplied in 60 count bottles.
To find out more about Memantine HCl Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
If you would like more information about this topic, please contact Megan Little at [email protected]
